| Active Ingredient | LETROZOLE |
| Therapeutic Class | ANTINEOPLASTICS |
| Indications | Advanced or locally advanced breast cancer in post menopausal women; adjuvant treatment of hormone-receptor-positive early breast cancer in post menopausal women; early invasive cancer in post menopa More ... |
| Caution | Hot flushes, nauear, vomiting, bone fractures, hypercholesterolemia. |
| Dose Range | 2.5mg daily . |
| Drug Interactions | |
| Pregnancy | Letrozole is contraindicated in women who are or may become pregnant (i.e., prem More ... |
| Breast Feeding | Not recommended during letrozole therapy. |